CellCarta, a global provider of precision medicine services, announced today the launch of imageDx PRISM to significantly advance the spatial biology data achievable from Akoya Bioscience ’s® multiplex immunofluorescence (mIF) assays.
Jan 1, 2022 | cellcarta.comCellCarta Group is excited to announce that Teiko Bio has partnered with CellCarta to create a dedicated access portal exclusively for their customers at cellengine.teiko.bio.
Jan 1, 2022 | cellcarta.com